Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) (SUNRISE 1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02783729
Recruitment Status : Completed
First Posted : May 26, 2016
Last Update Posted : November 27, 2018
Sponsor:
Collaborator:
Purdue Pharma LP
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 30, 2018
  Actual Study Completion Date : January 30, 2018
  Certification/Extension First Submitted : November 26, 2018